
Metsera
company0.0Global Dominance: 0.00%
Metsera is a biotechnology company focused on developing innovative weight loss medications, currently attracting attention due to its acquisition interest from major pharmaceutical firms like Pfizer and Novo Nordisk. The company is noted for having a unique treatment regimen that requires administration only once a month, positioning it competitively against other weight loss drugs in the market.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Metsera is at the center of a legal dispute involving Pfizer and Novo Nordisk regarding a purchase agreement.
Pfizer trækker Novo i retten i kamp om selskab med anderledes vægttabsmedicinPolitiken·
Denmark· 2025-11-01
Metsera has given Pfizer a deadline to come up with a better offer than Novo's.
Pfizer trækker Novo i retten i kamp om firma med anderledes vægttabsmedicinPolitiken·
Denmark· 2025-10-31



